Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | HPGD | P15428 | 2/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 3/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | GAA | P10253 | 2/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.43 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.42 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.41 |
| ▸ | KIF11 | P52732 | 1/20 | 0.41 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.41 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | GLA | P06280 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8360792 | 0.89 | ALDH1A1 (0.48) | ALDH1A1HPGDHSD17B10TDP1ALOX15 | |
| SCHEMBL24895100 | 0.84 | MPL (0.50) | ALDH1A1HPGDHSD17B10MEN1KMT2A | |
| SCHEMBL8356326 | 0.84 | CYP3A4 (0.44) | ALDH1A1HPGDHSD17B10MEN1KMT2A | |
| SCHEMBL11777447 | 0.83 | GLRA3 (0.50) | ALDH1A1HPGDHSD17B10TDP1ALOX15 | |
| SCHEMBL8356329 | 0.80 | CNR2 (0.46) | — | |
| SCHEMBL19195722 | 0.79 | GLRA3 (0.46) | ALDH1A1HPGDHSD17B10TDP1ALOX15 | |
| SCHEMBL11777345 | 0.79 | GLRA3 (0.46) | ALDH1A1HPGDHSD17B10TDP1ALOX15 | |
| SCHEMBL19196160 | 0.79 | GLRA3 (0.42) | ALDH1A1HPGDHSD17B10TDP1ALOX15 | |
| SCHEMBL19203353 | 0.78 | CSNK2A1 (0.52) | ALDH1A1HPGDHSD17B10TDP1MEN1 | |
| SCHEMBL7629173 | 0.78 | ALDH1A1 (0.55) | ALDH1A1HPGDHSD17B10TDP1ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11739223-B2 | Surface primer compositions and methods of use | ENVISTA (US) | 2023-08-29 | — | — | US | disclosed |
| US-11739223-B2 | Surface primer compositions and methods of use | ENVISTA (US) | 2023-08-29 | — | — | US | disclosed |
| US-10696698-B2 | Surface primer compositions and methods of use | ORMCO CORPORATION | 2020-06-30 | — | — | US | disclosed |
| US-20170217999-A1 | SURFACE PRIMER COMPOSITIONS AND METHODS OF USE | ORMCO CORPORATION | 2017-08-03 | — | — | US | disclosed |
| US-20170217999-A1 | SURFACE PRIMER COMPOSITIONS AND METHODS OF USE | ORMCO CORPORATION | 2017-08-03 | — | — | US | disclosed |
| EP-1172704-B1 | Toner | CANON KK (JP) | 2004-12-29 | — | — | EP | disclosed |
| US-6528222-B2 | Toner | CANON KABUSHIKI KAISHA (JP) | 2003-03-04 | — | — | US | disclosed |
| US-20020072005-A1 | Toner | CANON KABUSHIKI KAISHA (JP) | 2002-06-13 | — | — | US | disclosed |
| EP-1172704-A2 | Toner | CANON KABUSHIKI KAISHA (JP) | 2002-01-16 | — | — | EP | disclosed |
| US-5990332-A | EXCELLENT IN CHARGE CONTROL OR CHARGE-ENHANCING PROPERTY, AND TONER FOR DEVELOPING ELECTROSTATIC IMAGES AND POWDERY PAINT FOR ELECTROSTATIC PAINTING | ORIENT CHEMICAL INDUSTRIES, LTD. (JP) | 1999-11-23 | — | — | US | disclosed |
| US-5976749-A | TONER FOR DEVELOPING ELECTROSTATIC IMAGES | ORIENT CHEMICAL INDUSTRIES, LTD (JP) | 1999-11-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10696698-B2 | Surface primer compositions and methods of use | SP1, GPER1, GRIN1 | ALDH1A1 1177/4885HPGD 3336/4885HSD17B10 3466/4885 |
| US-20170217999-A1 | SURFACE PRIMER COMPOSITIONS AND METHODS OF USE | SP1, GPER1, GRIN1 | ALDH1A1 1177/4885HPGD 3336/4885HSD17B10 3466/4885 |
| US-11739223-B2 | Surface primer compositions and methods of use | SP1, GPER1, GRIN1 | ALDH1A1 1177/4885HPGD 3336/4885HSD17B10 3466/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.